Related Experiment Video
Updated: May 11, 2026
09:30
The Synthesis of RGD-functionalized Hydrogels as a Tool for Therapeutic Applications
Published on: October 7, 2016
11.2K
Responsive Hydrogel-Based Drug Delivery Platform for Osteoarthritis Treatment
Bin Yin1, Jianda Xu2, Jingqi Lu1
1Institute of Advanced Materials and Flexible Electronics (IAMFE), School of Chemistry and Materials Science, Nanjing University of Information Science and Technology, Nanjing 210044, China.
Gels (Basel, Switzerland)
|November 26, 2024
Summary
Injectable responsive hydrogels offer a promising new treatment for osteoarthritis (OA), a common joint disorder. These advanced drug delivery systems improve drug retention and targeted release, addressing limitations of current OA therapies.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Orthopedics
Background:
- Osteoarthritis (OA) is a leading cause of disability, characterized by articular cartilage degeneration.
- Current OA treatments, including pharmaceuticals and surgery, have significant limitations and side effects.
- Novel therapeutic strategies are crucial for effective OA management.
Purpose of the Study:
- To review recent advancements in injectable responsive hydrogel drug delivery platforms for osteoarthritis treatment.
- To highlight the advantages and potential of these platforms in enhancing OA therapy.
- To discuss challenges in the clinical translation of these innovative hydrogel systems.
Main Methods:
- Review of recent scientific literature on injectable responsive hydrogels for OA treatment.
- Analysis of hydrogel properties such as biocompatibility, drug loading, and release kinetics.
- Evaluation of stimulus-responsive mechanisms for targeted drug delivery.
Main Results:
- Injectable responsive hydrogels demonstrate superior biocompatibility and prolonged drug release compared to conventional methods.
- These platforms offer enhanced drug loading capacity and sensitivity for OA treatment.
- Key advantages include improved drug retention time and stimulus-responsive release at lesion sites.
Conclusions:
- Injectable responsive hydrogels represent a significant advancement in osteoarthritis therapeutics.
- These platforms offer new strategies for localized and sustained drug delivery, improving treatment efficacy.
- Further research and clinical translation are needed to fully realize the potential of hydrogel-based OA treatments.
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...